# Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation

> **NCT05408754** · NA · COMPLETED · sponsor: **Adagio Medical** · enrollment: 89 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Atrial ablation for subject scheduled for a de novo endocardial ablation of symptomatic, drug-refractory PsAF.

## Key facts

- **NCT ID:** NCT05408754
- **Lead sponsor:** Adagio Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-20
- **Primary completion:** 2024-10-14
- **Final completion:** 2025-03-03
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05408754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05408754, "Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05408754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
